Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss drugs.
16don MSN
Novo Nordisk sues telehealth company over 'knock-off' weight loss drugs, flags patient safety risks
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results